Ferroportin and iron regulation in breast cancer progression and prognosis
doi: 10.3389/fimmu.2025.1639196 Received 01 June 2025 Accepted 17 September 2025 Published 03 October 2025 Volume 16 - 2025 Edited by Haibo Dong, University of North Carolina at Greensboro, United States Reviewed by Dawit Tadese, Ethiopian Institute of Agricultural Research (EIAR), Ethiopia Ji Sun, China Medical University, China Xiaoliang Gao, Fourth Military Medical University, China Updates Copyright 2025 Wang, Duan, Zhao, Zhang, Yu and Zhao
New editorial review outlines how LeviaPatch is positioned in the supplement patch category, including berberine and chromium research, transdermal delivery questions, pricing disclosures, and clear distinctions from prescription GLP-1 medications
Nausea may be more pronounced at the beginning of treatment and may lessen as the body adjusts
Higher concentrations shift this balance